Clinical Trials in Red Deer, Alberta

A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

NCT ID: NCT07064473

This clinical trial is studying whether a new medicine called vicadrostat, when taken together with an existing diabetes medicine called empagliflozin, can help lower the risk of heart problems in ...

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

NCT ID: NCT06237452

The VE303 clinical trial is studying a new treatment called VE303 to see if it can help prevent repeated infections caused by Clostridioides difficile, often called C. diff. This trial is open to t...

A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo

NCT ID: NCT06163326

This clinical trial is studying a medication called ritlecitinib to see how safe and effective it is for people with non-segmental vitiligo, a skin condition that causes white patches due to a loss...

A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine

NCT ID: NCT06616194

This clinical trial is studying a medication called rimegepant, which is designed to help adolescents who experience frequent migraines. To be eligible for the study, participants should be between...

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

NCT ID: NCT06641466

This clinical trial is studying a medication called rimegepant, which is being tested to see how well it prevents menstrual migraines in women. Menstrual migraines are headaches that occur before o...

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

NCT ID: NCT07133308

A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis

NCT ID: NCT06863961

This clinical trial is studying a new treatment called RO7790121 for people with moderate to severe atopic dermatitis, which is a skin condition that causes itchy and inflamed skin. The goal of the...

A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

NCT ID: NCT06873945

This clinical trial is studying a medication called ritlecitinib to see how safe and effective it is for treating alopecia areata, a condition that causes significant hair loss on the scalp and oth...

A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis

NCT ID: NCT06550076

This clinical trial is studying a new medication called TAK-279 to see how well it works and how safe it is for people with moderate-to-severe plaque psoriasis, a skin condition that causes red, fl...

A Study to Investigate the Efficacy and Safety of Lebrikizumab in Participants With Moderate-to-Severe Atopic Hand and Foot Dermatitis

NCT ID: NCT06921759

This clinical trial is looking at a new treatment called lebrikizumab for adults and teenagers who have moderate-to-severe atopic hand and foot dermatitis, a condition that causes itchy and painful...

Alberta Collaborative QI Strategies to Improve Outcomes of Moderate and Late Preterm Infants (ABC-QI Trial)

NCT ID: NCT05231200

The ABC-QI Trial is a study focused on improving the care of preterm infants born between 32 and 36 weeks of pregnancy who need extra help in the hospital. The goal of the trial is to find out if u...

A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis

NCT ID: NCT06407934

This clinical trial is designed to evaluate how well two different doses of a medication called amlitelimab work for people aged 12 years and older with moderate-to-severe atopic dermatitis, a cond...

Optimizing the Management of Staphylococcus Aureus Bacteremia (OPTIMUS-SAB)

NCT ID: NCT06338176

The OPTIMUS-SAB clinical trial is focused on improving the care of patients with Staphylococcus aureus bacteremia (SAB), a serious bloodstream infection that can lead to significant health risks, e...

A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age

NCT ID: NCT05575492

This clinical trial is studying a new vaccine called mRNA-1647, which is designed to protect against cytomegalovirus (CMV). The main goal is to see how safe the vaccine is and how well it works in ...

Implementing REmote SymPtom mOnitoring and maNagement (RESPONd)

NCT ID: NCT07024329

This study is looking at whether using a remote symptom monitoring program can help people with cancer feel better and make their clinic visits more efficient. Participants will use a digital tool ...

A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy

NCT ID: NCT05958407

This clinical trial is studying a treatment called tralokinumab for people with moderate-to-severe atopic hand eczema, a skin condition that causes dry, itchy, and inflamed skin on the hands. The g...

Dialyzing Wisely - Improving the Delivery of Acute Renal Replacement Therapy to Albertans

NCT ID: NCT05186636

The "Dialyzing Wisely" clinical trial is focused on improving the way acute renal replacement therapy (RRT) is delivered to patients with acute kidney injury in Alberta. The goal is to use the best...

Evaluation of Effectiveness of Child-oriented Goal-setting in Paediatric Rehabilitation (the ENGAGE Approach)

NCT ID: NCT04096430

This clinical trial is studying a new way of setting goals for children with disabilities who are receiving rehabilitation therapy. The focus is on a child-friendly approach called the ENGAGE metho...

PGMP for Alberta Surgical Patients

NCT ID: NCT05036655